Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 22, pseudogene (RN7SL22P)

Target
RN7SL22P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 22, pseudogene" (RN7SL22P) is classified as a **pseudogene** of the non-coding RNA known as 7SL RNA, which is a component of the signal recognition particle (SRP) complex in its canonical form (RN7SL1)[9][1]. Pseudogenes are genomic sequences similar to known genes but are typically non-functional and do not code for functional products, usually due to disabling mutations or truncation[6][8]. RN7SL22P is not known to be expressed or functional, and there is no evidence establishing it as a therapeutic target, biomarker, or direct contributor to disease. Like other pseudogenes, it might retain some capacity for regulatory functions, such as generating non-coding RNAs involved in gene regulation (for example, as microRNA decoys or sources of endogenous siRNAs), but no such function has been specifically described for RN7SL22P to date[4][8].

Other names
RN7SL22P
02

Biological functions

Other (no known canonical biological function; possibility of RNA-based regulation as for some pseudogenes[4])
03

Disease associations

Other (no direct evidence for disease association for this specific pseudogene)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 22, pseudogene (RN7SL22P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 22, pseudogene (RN7SL22P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call